Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.
Ceribell has raised $50.0M in total funding. The most recent round was Series C. The last funding was announced in September 2022.
Ceribell's investors include RA Capital Management, Redmile Group, Union Chimique Belge, Ally Bridge Group, Longitude Capital.
Ceribell is headquartered in Mountain View, United States.
Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.
Ceribell is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ceribell — Funding & Investors." VCBacked, September 21, 2022, https://www.vcbacked.co/company/ceribell. Accessed November 11, 2026.
VCBacked. (2022). Ceribell — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/ceribell
{{cite web |title=Ceribell — Funding & Investors |url=https://www.vcbacked.co/company/ceribell |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Ceribell? Request a listing update